IP Library Granted Patent US 10,822,326
Granted Patent B2
US 10,822,326 · App. 16/519,552 · Granted Nov 3, 2020

Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation

Inventors: Brian Metcalf (South San Francisco, CA); Chihyuan Chuang (South San Francisco, CA)
Assignee: Global Blood Therapeutics, Inc.
C07D401/12C07D213/65C07D213/68C07D213/69C07D213/80C07D401/14C07D405/14C07D413/12C07D471/04C07D487/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,822,326
App. No.
16/519,552
Granted
Nov 3, 2020
Kind
B2
Abstract

Provided are substituted heteroaryl aldehydes and derivatives thereof that act as allosteric modulators of hemoglobin, methods and intermediates for their preparation, pharmaceutical compositions comprising the modulators, and methods for their use in treating disorders mediate by hemoglobin and disorders that would benefit from increased tissue oxygenation.

Claims (8)

1. A method for preparing a compound of formula (A):

or a salt thereof, comprising contacting a compound of formula (B):

with SOCl 2 under conditions sufficient to form a compound of formula (A) or a salt thereof.

2. The method of claim 1 , wherein the conditions sufficient to form a compound of formula (A) or a salt thereof comprise dichloromethane.

3. The method of claim 1 , further comprising preparing a compound of formula (B), wherein preparing a compound of formula (B) comprises contacting a compound of formula (C):

with a compound of formula (D):

under conditions sufficient to form a compound of formula (B).

4. The method of claim 3 , wherein the conditions sufficient to form a compound of formula (B) comprise Pd(dppf)Cl 2 .

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Oct 6, 2022
From: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 061620/0186 →
SECOND AMENDED AND RESTATED PATENT SECURITY AGREEMENT Recorded Dec 22, 2021
From: GLOBAL BLOOD THERAPEUTICS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 058575/0921 →
AMENDED AND RESTATED PATENT SECURITY AGREEMENT Recorded Dec 9, 2020
From: GLOBAL BLOOD THERAPEUTICS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 054664/0871 →
CONFIRMATORY ASSIGNMENT Recorded Mar 11, 2020
From: CYTOKINETICS, INC.
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 052146/0542 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2020
From: METCALF, BRIAN
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 052146/0456 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2020
From: CHUANG, CHIHYUAN
To: CYTOKINETICS, INC.
Reel/Frame 052146/0466 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2020
From: CYTOKINETICS, INC.
To: GLOBAL BLOOD THERAPEUTICS, INC.
Reel/Frame 052146/0514 →
SECURITY INTEREST Recorded Dec 20, 2019
From: GLOBAL BLOOD THERAPEUTICS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 051396/0312 →
Continuity (6)
Continuation 15864433 · Jan 8, 2018
Continuation 15391669 · Dec 27, 2016
Continuation 13730730 · Dec 28, 2012
Provisional Application 61661327 · Jun 18, 2012
Provisional Application 61581063 · Dec 28, 2011
Related Publication 20200190058A1 · Jun 18, 2020